Evidence map›Paper›PMID 32953407›Full record

ArticleBalkan journal of medical genetics : BJMG2020

The Effects of O

O G Yildiz, D Aslan, H Akalin, Y Erdem, O Canoz, A Aytekin, S Ozoner, M Dundar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

O G YildizDepartment of Radiation Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.
D AslanDepartment of Radiation Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.
H AkalinDepartment of Medical Genetics, Erciyes University, School of Medicine, Kayseri, Turkey.
Y ErdemDepartment of Basic Pharmaceutical Sciences, Erciyes University, School of Pharmaceutical Science, Kayseri, Turkey.
O CanozDepartment of Pathology, School of Medicine, Erciyes University, Kayseri, Turkey.
A AytekinDepartment of Radiation Oncology, Kayseri Training and Research Hospital, Kayseri, Turkey.
S OzonerDepartment of Radiation Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.
M DundarDepartment of Medical Genetics, Erciyes University, School of Medicine, Kayseri, Turkey.
Erciyes University · TRKayseri Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study examined the prognostic significance and treatment effect of promoter methylation of O

Indexed as

Glioblastoma (GB)O6-Methyl guanine methyl transferase (MGMT) methylationRadiotherapy (RT)

Identifiers

PMID32953407
PMCPMC7474218
OpenAlexW3082659488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.